Discover 1,670 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Atlanta’s leading healthcare centers are recruiting participants for studies focused on developing innovative treatments for conditions such as cancer, depression, high blood pressure, and kidney disease. Whether you’re searching for paid clinical research opportunities as a healthy volunteer or trials for specific conditions, Atlanta provides a wide range of research options to meet your needs.
Filter
2
Filter results
Results: 1,670
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
for
Arthritis, Psoriatic
Location: Marietta GA, Salisbury NC, Charlotte NC, Evansville IN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07321873
Phase 2, Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
for
Lupus Erythematosus, Systemic
Location: Marietta GA, Charlotte NC, Jackson TN, Fayetteville NC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07438496
Phase 3, Recruiting
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
for
Coronary Artery Disease (CAD)
Location: Marietta GA
Sponsor: HeartFlow, Inc.
Sex: All
Age: 18+
Code: NCT07479433
Recruiting
Continuous Dual Aspiration Technique With Zoom System for Stroke
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Episode (MDE), Major Depressive Disorder (MDD),
Location: Norcross GA, North Charleston SC, Jacksonville FL,
Sponsor: Tonix Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07621237
Phase 2, Recruiting
Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
for
Primary Biliary Cholangitis
Location: Marietta GA, Indianapolis IN, Houston TX
Sponsor: Zydus Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07216235
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus